Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Cardinal Health

S&P 500 Stock Market Winners Today

Oil stocks were S&P 500 winners Monday, including Diamondback Energy. Bristol Myers Squibb was among the big losers.

Investors Business Daily

In California's largest race bias cases, Latino workers are accused of abusing Black colleagues

Nearly every day, the onetime Ontario, California, warehouse employee said, he was stunned to hear racist slurs from Latino co-workers.

Los Angeles Times

Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Rallies After Inflation, Jobs Data; Disney Soars On Earnings

The Dow Jones Industrial Average rallied Thursday after a key inflation report. Disney stock soared almost 10% on strong earnings results.

Investors Business Daily

Recession Investing: 5 High Yield Dividend Stocks For A Downturn

As the healthcare industry absorbed enormous amounts of profits during the Covid-19 pandemic, many healthcare companies will be increasing shareholder distributions to entice investors to buy their stock.

Benzinga

WVa cities, counties reach $400M settlement with drug firms

West Virginia cities and counties have reached a $400 million tentative settlement with three major U.S. drug distributors

The Independent UK

Cardinal Health Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold

Cardinal Health sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

IBD Stock Of The Day McKesson Leads Wholesaler Rally, Nears A Breakout

McKesson is the IBD Stock Of The Day. A drug wholesaler rally is sending McKesson stock near a breakout. Rivals are also on the rise.

Investors Business Daily

A federal judge sides with 3 major drug distributors in a landmark opioid lawsuit

The lawsuit accused them of causing a health crisis by distributing 81 million pills over eight years in one West Virginia county ravaged by opioid addiction.

WEKU

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

The Independent UK

Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings

Cardinal Health Inc (NYSE:CAH) has reported Q3 FY22 adjusted EPS of $1.45, down 5% Y/Y, missing the consensus of $1.52 Q2 sales increased 14% Y/Y to $44.8 billion, beating the consensus estimate of $43.16 billion. The pharmaceutical segment increased 17% to $41 billion, driven primarily by branded pharmaceutical sales growth from large…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cardinal Health: Q3 Earnings Insights

Cardinal Health (NYSE:CAH) reported its Q3 earnings results on Thursday, May 5, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

The Independent UK

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

The Independent UK

WVa trial expert: Drug makers downplayed risks in marketing

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

US drug czar testifies in WVa lawsuit against opioid makers

The new White House drug czar has testified that the opioid epidemic got so bad in drug-ravaged West Virginia that the state was having trouble finding foster parents to care for children

The Independent UK

Trial begins in West Virginia lawsuit against opioid makers

Opening arguments have taken place in a West Virginia lawsuit accusing several drugmakers of misrepresenting the risks and benefits of opioids

Benzinga

This Favorable Sign Appears On Cardinal Health's Chart

If history is any guide, there may be good fortune ahead for shares of Cardinal Health (NYSE:CAH). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga

Expert Ratings For Cardinal Health

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga

Where Cardinal Health Stands With Analysts

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga

Cardinal Health's Return on Invested Capital Insights

According to Benzinga Pro data Cardinal Health (NYSE:CAH) posted a 81.99% decrease in earnings from Q1. Sales, however, increased by 3.39% over the previous quarter to $45.46 billion.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.